Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Batten

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2007
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7Frederic Sierro, Christine Biben, Laura Martínez-Muñoz, et al.
Oncoimmunology|February 1, 2020
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patientsTuba N Gide, Ines P Silva, Camelia Quek, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of diseaseGrant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.
The Journal of Clinical Investigation|January 10, 2002
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndromeJoanna Groom, Susan L Kalled, Anne H Cutler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical TrialsJarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Cancers|July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsTuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
The Journal of Experimental Medicine|November 25, 2010
IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cellsMarcel Batten, Nandhini Ramamoorthi, Noelyn M Kljavin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2016
IL-27 Directly Enhances Germinal Center B Cell Activity and Potentiates Lupus in Sanroque MiceDipti Vijayan, Norhanani Mohd Redzwan, Danielle T Avery, et al.
Immunity|June 12, 2016
Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis RiskKara G Lassen, Craig I McKenzie, Muriel Mari, et al.
Research Square|January 16, 2026
Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy ResponseAlexander Swarbrick, Ghamdan Al-Eryani, Sophie van der Leij, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2007
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7Frederic Sierro, Christine Biben, Laura Martínez-Muñoz, et al.
Oncoimmunology|February 1, 2020
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patientsTuba N Gide, Ines P Silva, Camelia Quek, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of diseaseGrant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.
The Journal of Clinical Investigation|January 10, 2002
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndromeJoanna Groom, Susan L Kalled, Anne H Cutler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical TrialsJarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Cancers|July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic TargetsTuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
The Journal of Experimental Medicine|November 25, 2010
IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cellsMarcel Batten, Nandhini Ramamoorthi, Noelyn M Kljavin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2016
IL-27 Directly Enhances Germinal Center B Cell Activity and Potentiates Lupus in Sanroque MiceDipti Vijayan, Norhanani Mohd Redzwan, Danielle T Avery, et al.
Immunity|June 12, 2016
Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis RiskKara G Lassen, Craig I McKenzie, Muriel Mari, et al.
Research Square|January 16, 2026
Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy ResponseAlexander Swarbrick, Ghamdan Al-Eryani, Sophie van der Leij, et al.
Pageof 4